Ftse Mib
34.600,00
-0,65%
DAX
18.726,76
-0,21%
S&P 500
5.310,44
0,04%
NASDAQ
16.782,40
-0,07%
Bitcoin
69.824,78
-2,28%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ NewLink Genetics Corporation (NLNK) NewLink Genetics Corporation (NLNK) Notizie

NLNK

NewLink Genetics (NLNK)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NLNK
DataOraFonteTitoloSimboloCompagnia
09/06/202023:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NLNKNewLink Genetics Corporation
02/06/202023:22Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NLNKNewLink Genetics Corporation
01/06/202012:29Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:NLNKNewLink Genetics Corporation
29/04/202022:15Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:NLNKNewLink Genetics Corporation
07/04/202023:59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NLNKNewLink Genetics Corporation
07/04/202022:45Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NLNKNewLink Genetics Corporation
01/04/202012:02Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:NLNKNewLink Genetics Corporation
31/03/202000:33Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NLNKNewLink Genetics Corporation
30/03/202014:00GlobeNewswire Inc.Lumos Pharma Appoints Joseph S. McCracken, DVM, MS to Board of Directors Rick Hawkins, CEO, appointed Chairman of the BoardNASDAQ:NLNKNewLink Genetics Corporation
18/03/202013:00GlobeNewswire Inc.NewLink Genetics Stockholders Approve Merger with Lumos PharmaNASDAQ:NLNKNewLink Genetics Corporation
06/03/202014:14Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NLNKNewLink Genetics Corporation
03/03/202022:28Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NLNKNewLink Genetics Corporation
28/02/202015:00GlobeNewswire Inc.NewLink Genetics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate UpdateNASDAQ:NLNKNewLink Genetics Corporation
18/02/202016:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NLNKNewLink Genetics Corporation
14/02/202021:24Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NLNKNewLink Genetics Corporation
13/02/202022:39Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:NLNKNewLink Genetics Corporation
10/02/202014:32Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:NLNKNewLink Genetics Corporation
04/02/202014:04Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:NLNKNewLink Genetics Corporation
23/12/201922:05GlobeNewswire Inc.NewLink Genetics Announces Exclusive Worldwide License Agreement with Ellipses Pharma for Development of and Rights to Commer...NASDAQ:NLNKNewLink Genetics Corporation
20/12/201916:09GlobeNewswire Inc.NewLink Genetics Announces FDA Approval of Ebola Vaccine V920 (ERVEBO®)NASDAQ:NLNKNewLink Genetics Corporation
16/12/201914:00GlobeNewswire Inc.NewLink Genetics Responds to Proposal from EvercelNASDAQ:NLNKNewLink Genetics Corporation
13/12/201915:12Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)NASDAQ:NLNKNewLink Genetics Corporation
12/12/201923:31GlobeNewswire Inc.Evercel Announces Rejected Offer to Acquire NewLink GeneticsNASDAQ:NLNKNewLink Genetics Corporation
20/11/201912:39Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (prem14a)NASDAQ:NLNKNewLink Genetics Corporation
12/11/201915:00GlobeNewswire Inc.NewLink Genetics Announces European Commission Grant of Conditional Marketing Approval for Ebola Vaccine V920 (ERVEBO®)NASDAQ:NLNKNewLink Genetics Corporation
06/11/201914:00GlobeNewswire Inc.NewLink Genetics Reports Third Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:NLNKNewLink Genetics Corporation
30/10/201913:30GlobeNewswire Inc.NewLink Genetics to Host Its Third Quarter 2019 Conference Call on November 6, 2019NASDAQ:NLNKNewLink Genetics Corporation
21/10/201922:30GlobeNewswire Inc.NewLink Genetics Announces EU Regulatory Committee (CHMP) Recommendation for Conditional Marketing Authorization for Ebola Va...NASDAQ:NLNKNewLink Genetics Corporation
30/09/201922:35GlobeNewswire Inc.NewLink Genetics and Lumos Pharma Enter into Merger Agreement to Form Biopharmaceutical Company Focused on Developing Therapi...NASDAQ:NLNKNewLink Genetics Corporation
17/09/201923:05GlobeNewswire Inc.NewLink Genetics Announces FDA Accepts Partnered Biologics License Application (BLA) and Grants Priority Review for Ebola Vac...NASDAQ:NLNKNewLink Genetics Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NLNK

La tua Cronologia

COIN
POLKEUR
Polkamarkets
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network